Antioxidant trial aims to tame dangerous COPD Flare-Ups
NCT ID NCT07456176
Summary
This study is testing if adding an antioxidant supplement called Alpha-Lipoic Acid (ALA) to standard hospital care helps people recover from a sudden, severe worsening of COPD symptoms. Researchers will compare two different doses of ALA against a placebo in 75 hospitalized patients to see if it reduces lung inflammation, helps patients stabilize faster, and shortens their hospital stay. The goal is to see if this supplement can help control the disease during these critical flare-ups.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE EXACERBATION CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Matareya Teaching Hospital
Cairo, 11856, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.